Search Results - "Lefesvre, P"

Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications by Martens, S., Lefesvre, P., Nicolle, R., Biankin, A.V., Puleo, F., Van Laethem, J.L., Rooman, I.

“…Different histological and molecular subtypes of pancreatic ductal adenocarcinoma (PDAC), with different molecular composition and survival statistics, have…”
Get full text

A novel cell population in the healthy pancreas that shares characteristics with the most aggressive pancreatic cancer by Martens, S., Coolens, K., Van Bulck, M., Madhloum, H., Esni, F., Leuckx, G., Heimberg, H., Bouwens, L., Jacquemin, P., De Paep, D., Veld, P. in't, Lefesvre, P., Real, F.X., Rovira, M., Rooman, I.

Get full text

Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone by Carrasco, J, Gizzi, M, Pairet, G, Lannoy, V, Lefesvre, P, Gigot, J-F, Hubert, C, Jouret-Mourin, A, Humblet, Y, Canon, J-L, Sempoux, C, Chapaux, X, Danse, E, Tinton, N, Navez, B, Van den Eynde, M

“…Background: Optimal preoperative treatment before colorectal cancer metastases (CRCM) resection remains unclear. This study evaluated pathological responses…”
Get full text

Genetic heterogeneity in response to adenovirus gene therapy by Lefesvre, Pierre, Attema, Joline, Lemckert, Angelique, Havenga, Menzo, van Bekkum, Dirk

“…After intravenous delivery of the adenoviral vector into rats or mice, 95-99% of the encoded protein is produced in the hepatocytes. We observed, as have…”
Get full text

Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications by Martens, S, Lefesvre, P, Nicolle, R, Biankin, A V, Puleo, F, Van Laethem, J L, Rooman, I

“…Different histological and molecular subtypes of pancreatic ductal adenocarcinoma (PDAC), with different molecular composition and survival statistics, have…”
Get full text

Comparison of Pathological Responses (PR) Observed on Colorectal Cancer Metastases (CRCM) Resected After Different Preoperative Treatments by van den Eynde, M., Gizzi, M., Pairet, G., Lefesvre, P., Lannoy, V., Gigot, J., Navez, B., Canon, J., Sempoux, C., Carrasco, J.

Get full text

578P - Comparison of Pathological Responses (PR) Observed on Colorectal Cancer Metastases (CRCM) Resected After Different Preoperative Treatments by van den Eynde, M., Gizzi, M., Pairet, G., Lefesvre, P., Lannoy, V., Gigot, J., Navez, B., Canon, J., Sempoux, C., Carrasco, J.

“…Irinotecan (IR) or oxaliplatin (OX)-based regimens optionally combined with anti-VEGF or anti-EGFR Target Therapies (TT) are used as preoperative treatment for…”
Get full text

Global histone modifications predict prognosis of resected non-small cell lung cancer patients by Barlesi, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A., Rodriguez, J.

“…Abstract only 7662 Background: Epigenetic modifications, such as methylation and/or acetylation of histones, may contribute to the development and progression…”
Get full text

A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer by Lefesvre, Pierre, Attema, Joline, van Bekkum, Dirk

“…Electroporation of skeletal muscle after injection of naked DNA was shown by others to increase transgene expression. Information regarding tissue damage…”
Get full text

Transfer of the Full-Length Dystrophin-Coding Sequence into Muscle Cells by a Dual High-Capacity Hybrid Viral Vector with Site-Specific Integration Ability by GONCALVES, Manuel A. F. V, VAN NIEROP, Gijsbert P, TIJSSEN, Marloes R, LEFESVRE, Pierre, KNAÄN-SHANZER, Shoshan, VAN DER VELDE, Ietje, VAN BEKKUM, Dirk W, VALERIO, Dinko, DE VRIES, Antoine A. F

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

A patient with very high serum level of human chorionic gonadotrophin; the diagnosis is not always a germ-cell tumour by van der Vliet, H J J, Lefesvre, P, van Groeningen, C J

“…A 47-year-old man, who presented with dyspnoea, gynaecomasty, and aphasia due to an extensively metastasized malignancy, was transferred to the hospital for…”
Get more information

Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth by Lefesvre, Pierre, Attema, Joline, van Bekkum, Dirk

“…The outgrowth of new vessels--angiogenesis--in the tumour mass is considered to be a limiting factor of tumour growth. To inhibit the matrix lysis that is part…”
Get full text